Price
Target price
€2.13
€2.13
1.430%
0.03
1.430%
€17.15
11:16 / Tradegate
WKN: A2DT49 / Symbol: IOVA / Name: Iovance Biotherapeutics / Stock / Biotechnology & Medical Research / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Iovance Biotherapeutics Inc. Stock
There is an upward development for Iovance Biotherapeutics Inc. compared to yesterday, with an increase of €0.030 (1.430%).
With 17 Buy predictions and only 2 Sell predictions the community sentiment for the stock is positive.
With a target price of 17 € there is potential for a 698.5% increase which would mean more than doubling the current price of 2.13 € for Iovance Biotherapeutics Inc..
So far the community has only identified positive things for Iovance Biotherapeutics Inc. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Iovance Biotherapeutics Inc. in the next few years
Pros
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Cons
?
B****
?
S********** s********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Iovance Biotherapeutics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Iovance Biotherapeutics Inc. | 1.430% | -7.513% | 22.763% | -77.125% | -69.606% | -82.982% | -91.060% |
| Ironwood Pharmaceuticals | -1.090% | 35.294% | 46.032% | -75.916% | -78.095% | -91.962% | -89.302% |
| Novocure Ltd | 4.340% | 0.465% | -33.525% | -40.103% | -65.907% | -88.146% | -84.483% |
| Arrowhead Pharmaceuticals Inc. | 2.050% | 16.939% | 2.905% | -21.748% | -12.841% | -63.554% | -54.598% |
Comments
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) had its price target lowered by analysts at Wells Fargo & Company from $18.00 to $14.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for IOVA provided by MarketBeat
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) had its price target lowered by analysts at Chardan Capital from $25.00 to $20.00. They now have a "buy" rating on the stock.
Show more
Ratings data for IOVA provided by MarketBeat
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $25.00 price target on the stock.
Show more
Ratings data for IOVA provided by MarketBeat